Evidence map›Paper›PMID 29920327›Full record

ArticleBrain, behavior, and immunity2018

Maternal prenatal depression predicts infant negative affect via maternal inflammatory cytokine levels.

Hanna C Gustafsson, Elinor L Sullivan, Elizabeth K Nousen, Ceri A Sullivan, Elaine Huang, Monica Rincon, Joel T Nigg, Jennifer M Loftis

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Psychedelic therapy and postpartum depression: priorities and prospects.Therapeutic advances in psychopharmacology · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hanna C GustafssonOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA. Electronic address: gustafha@ohsu.edu.
Elinor L SullivanOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA; Oregon National Primate Research Center, 505 NW 185th Avenue, Beaverton, OR, USA; University of Oregon, 1585 E 13th Ave, Eugene, OR, USA. Electronic address: sullivel@ohsu.edu.
Elizabeth K NousenOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA. Electronic address: nousen@ohsu.edu.
Ceri A SullivanOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA. Electronic address: sullivce@ohsu.edu.
Elaine HuangOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA; VA Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR, USA. Electronic address: huange@ohsu.edu.
Monica RinconOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA. Electronic address: rincon@ohsu.edu.
Joel T NiggOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA. Electronic address: niggj@ohsu.edu.
Jennifer M LoftisOregon Health and Science University, 3181 SW Sam Jackson Park Rd., Portland, OR, USA; VA Portland Health Care System, 3710 SW US Veterans Hospital Rd, Portland, OR, USA. Electronic address: loftisj@ohsu.edu.
Oregon Health & Science University · USVA Portland Health Care System · US

Funding

ADHD heterogeneity, mechanisms, and risk profileR37MH059105 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIGG, JOEL T · 2014 to 2023
$7.0M
Oregon Clinical and Translational Research Institute TL1 ProgramTL1TR002371 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, JESSINA C MCGREGOR · 2017 to 2026
$6.2M
The Impact of Maternal Obesity and Poor Antenatal Nutrition on Offspring RDoC Dimensions and Risk for Neurodevelopmental DisordersR01MH117177 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI NIGG, JOEL T, SULLIVAN, ELINOR L. · 2018 to 2022
$3.6M
NCATS NIH HHS TL1 TR002371NIMH NIH HHS R01 MH117177NIMH NIH HHS R37 MH059105
6 · The paper itself

Abstract

Maternal depressive symptoms during pregnancy are associated with risk for offspring emotional and behavioral problems, but the mechanisms by which this association occurs are not known. Infant elevated negative affect (increased crying, irritability, fearfulness, etc.) is a key risk factor for future psychopathology, so understanding its determinants has prevention and early intervention potential. An understudied yet promising hypothesis is that maternal mood affects infant mood via maternal prenatal inflammatory mechanisms, but this has not been prospectively examined in humans. Using data from a pilot study of women followed from the second trimester of pregnancy through six months postpartum (N = 68) our goal was to initiate a prospective study as to whether maternal inflammatory cytokines mediate the association between maternal depressive symptoms and infant offspring negative affect. The study sample was designed to examine a broad range of likely self-regulation and mood-regulation problems in offspring; to that end we over-selected women with a family history or their own history of elevated symptoms of attention-deficit/hyperactivity disorder. Results supported the hypothesis: maternal pro-inflammatory cytokines during the third trimester (indexed using a latent variable that included plasma interleukin-6, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 concentrations as indicators) mediated the effect, such that higher maternal depressive symptoms were associated with higher maternal inflammation, and this mediated the effect on maternal report of infant negative affect (controlling for maternal affect during the infant period). This is the first human study to demonstrate that maternal inflammatory cytokines mediate the association between prenatal depression and infant outcomes, and the first to demonstrate a biological mechanism through which depressive symptoms impact infant temperament.

Indexed as

AdultAffectAffective SymptomsAnxietyCytokinesDepressionDepressive DisorderEmotionsFemaleForecastingHumansInfantInfant, NewbornInflammationMiddle AgedMothersCytokinesCytokinesInfant temperamentInflammationNegative affectPrenatal depression

Identifiers

PMID29920327
PMCPMC6129422
OpenAlexW2765565396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.